SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem (India) - Quaterly Results

10 Nov 2021 Evaluate
The Sales for the quarter ended September 2021 of Rs. 126.66 million declined by -34.00% from Rs. 191.90 millions.The Net Loss for the quarter ended September 2021 is Rs. -17.13 millions as compared to Net Loss of Rs. -10.10 millions of corresponding quarter ended September 2020 Operating profit Margin for the quarter ended September 2021 further decreased to -10.57% as compared to -4.13% of corresponding quarter ended September 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 126.66 191.90 -34.00 322.19 310.54 3.75 744.15 880.16 -15.45
Other Income 0.20 0.00 0.00 0.22 0.79 -72.15 2.56 0.90 184.44
PBIDT -10.57 -4.13 155.93 -19.18 -2.30 733.91 -49.04 -0.33 14760.61
Interest 0.22 0.22 0.00 0.30 0.24 25.00 0.55 0.18 205.56
PBDT -10.79 -4.35 148.05 -19.48 -2.54 666.93 -49.59 -0.51 9623.53
Depreciation 6.34 5.75 10.26 12.54 11.41 9.90 23.55 21.50 9.53
PBT -17.13 -10.10 69.60 -32.02 -13.95 129.53 -73.14 -22.01 232.30
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -17.49 -3.47 404.03
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -17.49 -3.47 404.03
PAT -17.13 -10.10 69.60 -32.02 -13.95 129.53 -55.65 -18.54 200.16
Equity 232.90 215.40 8.12 232.90 215.40 8.12 215.40 187.90 14.64
PBIDTM(%) -8.35 -2.15 287.75 -5.95 -0.74 703.81 -6.59 -0.04 17473.60

Syschem (India) Share Price

52.87 0.74 (1.42%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×